Moreover, genetic alterations in the transcriptional coregulators of ER genes are likely to be the key players in the development of estrogen-dependent tumors through deregulation in the estrogen signaling pathway (Girault et al., 2006), further supporting our hypothesis for WHSC1 as the likely target gene in endometrial cancer. Here, NSD2 is linked to substance dependence.